For the twelve months ended Sep 30, 2026, Universal Health Realty Income Trust reported $99.34M of revenue and $20.18M of net income.
UHT revenue was $25.35M in fiscal Q3 2026 (ended Sep 30, 2026), up 0.2% from a year earlier and up 1.4% from the prior quarter. For the full fiscal 2025 it was $99.19M, up 0.2% from fiscal 2024. Compound annual growth was +4.9% over 5 years and +4.5% over 10 years. It rose in each of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
UHT net income was $4.93M in fiscal Q3 2026 (ended Sep 30, 2026), up 22.7% from a year earlier and down 16.6% from the prior quarter. For the full fiscal 2025 it was $17.61M, down 8.4% from fiscal 2024. Compound annual growth was -2.0% over 5 years and -2.9% over 10 years. It rose in 4 of the last 10 fiscal years.
UHT diluted EPS was $0.35 in fiscal Q3 2026 (ended Sep 30, 2026), up 20.7% from a year earlier and down 18.6% from the prior quarter. For the full fiscal 2025 it was $1.27, down 8.6% from fiscal 2024. Compound annual growth was -2.1% over 5 years.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99.19M | $99.01M | $95.58M | $90.63M | $84.19M | $78.01M | $77.16M | $76.21M | $72.35M | $67.08M |
| Operating income | $34.76M | $36.80M | $31.35M | $30.67M | $28.86M | $26.00M | $25.75M | $26.70M | $24.04M | $22.11M |
| Net income | $17.61M | $19.23M | $15.40M | $21.10M | $109.17M | $19.45M | $18.96M | $24.20M | $45.62M | $17.21M |
| EPS, basic | $1.27 | $1.39 | $1.12 | $1.53 | $7.94 | $1.42 | $1.38 | $1.76 | $3.35 | $1.28 |
| EPS, diluted | $1.27 | $1.39 | $1.11 | $1.53 | $7.92 | $1.41 | $1.38 | $1.76 | $3.35 | $1.28 |
| Diluted shares | 13.9M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.7M | 13,625 | 13,468 |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $6.69M | $7.10M | $8.21M | $7.61M | $22.50M | $5.74M | $6.11M | $5.04M | $3.39M | $3.93M |
| Total assets | $564.91M | $580.86M | $596.37M | $607.54M | $598.42M | $494.01M | $488.79M | $483.76M | $490.01M | $524.75M |
| Total debt | $374.77M | $368.41M | $359.66M | $343.05M | $329.05M | $295.43M | $274.09M | $261.75M | $256.79M | $315.66M |
| Total liabilities | $412.52M | $401.32M | $395.44M | $378.44M | $363.09M | $335.00M | $307.06M | $285.15M | $279.45M | $333.47M |
| Shareholders' equity | $152.38M | $179.54M | $200.93M | $229.10M | $235.33M | $159.00M | $181.73M | $198.61M | $210.56M | $191.28M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $49.09M | $46.91M | $42.94M | $46.80M | $47.73M | $44.21M | $42.65M | $42.93M | $46.01M | $40.73M |
| Capital expenditures | - | - | $7.62M | $13.62M | $12.99M | $2.27M | $5.11M | $4.05M | $9.04M | $60.39M |
| Free cash flow | - | - | $35.32M | $33.19M | $34.74M | $41.94M | $37.55M | $38.88M | $36.97M | -$19.66M |
| Investing cash flow | -$14.96M | -$13.88M | -$19.11M | -$36.67M | -$24.43M | -$27.21M | -$16.47M | -$7.96M | $39.46M | -$74.83M |
| Financing cash flow | -$34.55M | -$34.15M | -$23.23M | -$25.02M | -$6.54M | -$17.37M | -$25.11M | -$33.32M | -$86.01M | $34.14M |
| Dividends paid | $41.03M | $40.39M | $39.77M | $39.18M | $38.53M | $37.97M | $37.41M | $36.83M | $36.05M | $35.14M |
| Share repurchases | - | - | - | - | - | $235.0K | $221.0K | - | - | - |
| Stock-based compensation | $936.0K | $853.0K | $780.0K | $780.0K | $947.0K | $912.0K | $702.0K | $571.0K | $538.0K | $481.0K |
| Depreciation and amortization | $28.86M | $27.42M | $27.73M | $26.56M | $27.48M | $25.58M | $25.87M | $24.98M | $25.09M | $23.01M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 0.2% | 3.6% | 5.5% | 7.6% | 7.9% | 1.1% | 1.3% | 5.3% | 7.9% | 4.9% |
| Net income growth, YoY | -8.4% | 24.9% | -27.0% | -80.7% | 461.4% | 2.5% | -21.6% | -47.0% | 165.0% | -27.3% |
| EPS growth, YoY | -8.6% | 25.2% | -27.5% | -80.7% | 461.7% | 2.2% | -21.6% | - | 161.7% | - |
| Operating margin | 35.0% | 37.2% | 32.8% | 33.8% | 34.3% | 33.3% | 33.4% | 35.0% | 33.2% | 33.0% |
| Net margin | 17.8% | 19.4% | 16.1% | 23.3% | 129.7% | 24.9% | 24.6% | 31.7% | 63.1% | 25.7% |
| Free cash flow margin | - | - | 37.0% | 36.6% | 41.3% | 53.8% | 48.7% | 51.0% | 51.1% | -29.3% |
| Return on equity | 11.6% | 10.7% | 7.7% | 9.2% | 46.4% | 12.2% | 10.4% | 12.2% | 21.7% | 9.0% |
| Return on assets | 3.1% | 3.3% | 2.6% | 3.5% | 18.2% | 3.9% | 3.9% | 5.0% | 9.3% | 3.3% |
| Debt to equity | 2.46 | 2.05 | 1.79 | 1.50 | 1.40 | 1.86 | 1.51 | 1.32 | 1.22 | 1.65 |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25.35M | $24.99M | $24.53M | $24.47M | $25.30M | $24.87M | $24.55M | $24.64M | $24.49M | $24.73M | $25.14M | $24.32M |
| Operating income | $8.96M | $9.20M | $8.96M | $8.49M | $8.39M | $8.84M | $9.03M | $9.26M | $8.49M | $9.58M | $9.46M | $8.15M |
| Net income | $4.93M | $5.91M | $5.02M | $4.32M | $4.02M | $4.49M | $4.78M | $4.66M | $4.00M | $5.28M | $5.30M | $3.59M |
| EPS, basic | $0.36 | $0.43 | $0.36 | $0.30 | $0.29 | $0.33 | $0.35 | $0.34 | $0.29 | $0.38 | $0.38 | $0.27 |
| EPS, diluted | $0.35 | $0.43 | $0.36 | $0.32 | $0.29 | $0.32 | $0.34 | $0.34 | $0.29 | $0.38 | $0.38 | $0.26 |
| Diluted shares | 13.9M | 13.9M | 13.9M | - | 13.9M | 13.9M | 13.9M | - | 13.8M | 13.8M | 13.8M | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $6.47M | $6.82M | $7.06M | $6.69M | $6.92M | $6.55M | $6.97M | $7.10M | $6.37M | $5.58M | $7.70M | $8.21M |
| Total assets | $573.01M | $567.12M | $563.76M | $564.91M | $568.04M | $573.02M | $573.48M | $580.86M | $584.33M | $586.55M | $596.19M | $596.37M |
| Total debt | - | - | - | $374.77M | - | - | - | $368.41M | - | - | - | $359.66M |
| Total liabilities | $433.51M | $423.21M | $415.96M | $412.52M | $409.46M | $407.86M | $401.32M | $401.32M | $402.69M | $395.85M | $399.73M | $395.44M |
| Shareholders' equity | $139.50M | $143.91M | $147.80M | $152.38M | $158.57M | $165.15M | $172.17M | $179.54M | $181.64M | $190.70M | $196.46M | $200.93M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $9.12M | $12.40M | $11.95M | $13.60M | $10.20M | $13.69M | $11.61M | $13.15M | $9.89M | $12.13M | $11.74M | $10.46M |
| Capital expenditures | - | - | - | - | - | - | - | - | - | - | - | $22.0K |
| Free cash flow | - | - | - | - | - | - | - | - | - | - | - | $10.43M |
| Investing cash flow | -$11.18M | -$7.84M | -$4.46M | -$2.52M | -$1.75M | -$8.79M | -$1.90M | -$2.71M | -$1.50M | -$722.0K | -$8.95M | $735.0K |
| Financing cash flow | $1.71M | -$4.81M | -$7.12M | -$11.30M | -$8.09M | -$5.32M | -$9.84M | -$9.72M | -$7.60M | -$13.53M | -$3.31M | -$11.34M |
| Dividends paid | $10.40M | $10.50M | $10.30M | $10.31M | $10.30M | $10.30M | $10.15M | $10.15M | $10.10M | $10.20M | $10.00M | $10.00M |
| Stock-based compensation | $224.0K | $203.0K | $190.0K | $274.0K | $236.0K | $213.0K | $213.0K | $218.0K | $222.0K | $211.0K | $202.0K | $203.0K |
| Depreciation and amortization | $7.05M | $7.03M | $6.95M | $7.12M | $7.90M | $6.99M | $6.84M | $6.80M | $7.01M | $6.81M | $6.81M | $7.25M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 0.2% | 0.5% | -0.1% | -0.7% | 3.3% | 0.5% | -2.4% | 1.3% | 1.1% | 3.9% | 8.2% | 0.8% |
| Net income growth, YoY | 22.7% | 31.5% | 5.1% | -7.2% | 0.5% | -14.9% | -9.9% | 29.7% | 3.2% | 51.8% | 18.9% | -36.2% |
| EPS growth, YoY | 20.7% | 34.4% | 5.9% | -5.9% | 0.0% | -15.8% | -10.5% | 30.8% | 3.6% | 52.0% | 18.8% | -36.6% |
| Operating margin | 35.4% | 36.8% | 36.5% | 34.7% | 33.2% | 35.6% | 36.8% | 37.6% | 34.7% | 38.7% | 37.6% | 33.5% |
| Net margin | 19.4% | 23.6% | 20.5% | 17.7% | 15.9% | 18.1% | 19.5% | 18.9% | 16.3% | 21.3% | 21.1% | 14.8% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - | - | 42.9% |
| Debt to equity | - | - | - | 2.46 | - | - | - | 2.05 | - | - | - | 1.79 |
Source: XBRL data Universal Health Realty Income Trust files with the SEC, latest filing dated Nov 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| UHT | $99.34M | -0.0% | $20.18M | 20.3% | $543.6M |
| O | $6.21B | +10.8% | $1.36B | 21.8% | $56.15B |
| UHS | $18.35B | +8.0% | $1.46B | 8.0% | $11.52B |
| HR | $1.13B | -5.8% | -$44.93M | -4.0% | $6.50B |